Richard Warren

61PUBLICATIONS
156CO-AUTHORS
Medical infection agents (incl. prions)PharmacogenomicsGene and molecular therapyToxicology (incl. clinical toxicology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (61)

|Sep 15, 2026
Risks of tuberculosis, meningitis, candidiasis, and fungal infections among patients receiving systemic treatments for psoriasis: a nationwide cohort study from BADBIR data.

|Aug 07, 2026
Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials.

|Aug 01, 2026
Healthcare resource use, costs and health-related quality of life in the UK-Irish Atopic eczema Systemic Therapy Register (A-STAR): a pilot study.

|Jul 08, 2026
Cost-Utility Analyses of Systemic Treatments for Psoriasis and Psoriatic Arthritis in the UK: A Systematic Review of Modelling Methods.

|May 04, 2026
Serious infection risk with systemic treatments for psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).

|Apr 30, 2026
Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study.

Pageof 11

Frequent Collaborators

23 joint publications

Zenas Z N Yiu

11 joint publications

Christopher Ernest Maitland Griffiths

8 joint publications

Philip Laws

7 joint publications

Catherine H Smith